IBDEI0EI ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6997,2)
 ;;=^124400
 ;;^UTILITY(U,$J,358.3,6998,0)
 ;;=V13.01^^55^575^25
 ;;^UTILITY(U,$J,358.3,6998,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6998,1,4,0)
 ;;=4^V13.01
 ;;^UTILITY(U,$J,358.3,6998,1,5,0)
 ;;=5^Hx Of Kidney Stone
 ;;^UTILITY(U,$J,358.3,6998,2)
 ;;=^303403
 ;;^UTILITY(U,$J,358.3,6999,0)
 ;;=302.71^^55^575^36
 ;;^UTILITY(U,$J,358.3,6999,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6999,1,4,0)
 ;;=4^302.71
 ;;^UTILITY(U,$J,358.3,6999,1,5,0)
 ;;=5^Loss Of Libido
 ;;^UTILITY(U,$J,358.3,6999,2)
 ;;=^1
 ;;^UTILITY(U,$J,358.3,7000,0)
 ;;=596.54^^55^575^38
 ;;^UTILITY(U,$J,358.3,7000,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7000,1,4,0)
 ;;=4^596.54
 ;;^UTILITY(U,$J,358.3,7000,1,5,0)
 ;;=5^Neurogenic Bladder 
 ;;^UTILITY(U,$J,358.3,7000,2)
 ;;=^304798
 ;;^UTILITY(U,$J,358.3,7001,0)
 ;;=788.43^^55^575^39
 ;;^UTILITY(U,$J,358.3,7001,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7001,1,4,0)
 ;;=4^788.43
 ;;^UTILITY(U,$J,358.3,7001,1,5,0)
 ;;=5^Nocturia
 ;;^UTILITY(U,$J,358.3,7001,2)
 ;;=^84740
 ;;^UTILITY(U,$J,358.3,7002,0)
 ;;=605.^^55^575^42
 ;;^UTILITY(U,$J,358.3,7002,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7002,1,4,0)
 ;;=4^605.
 ;;^UTILITY(U,$J,358.3,7002,1,5,0)
 ;;=5^Phimosis
 ;;^UTILITY(U,$J,358.3,7002,2)
 ;;=^104159
 ;;^UTILITY(U,$J,358.3,7003,0)
 ;;=601.0^^55^575^44
 ;;^UTILITY(U,$J,358.3,7003,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7003,1,4,0)
 ;;=4^601.0
 ;;^UTILITY(U,$J,358.3,7003,1,5,0)
 ;;=5^Prostatitis, Acute
 ;;^UTILITY(U,$J,358.3,7003,2)
 ;;=^259106
 ;;^UTILITY(U,$J,358.3,7004,0)
 ;;=590.10^^55^575^46
 ;;^UTILITY(U,$J,358.3,7004,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7004,1,4,0)
 ;;=4^590.10
 ;;^UTILITY(U,$J,358.3,7004,1,5,0)
 ;;=5^Pyelonephritis, Acute
 ;;^UTILITY(U,$J,358.3,7004,2)
 ;;=^270369
 ;;^UTILITY(U,$J,358.3,7005,0)
 ;;=590.00^^55^575^47
 ;;^UTILITY(U,$J,358.3,7005,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7005,1,4,0)
 ;;=4^590.00
 ;;^UTILITY(U,$J,358.3,7005,1,5,0)
 ;;=5^Pyelonephritis, Chronic
 ;;^UTILITY(U,$J,358.3,7005,2)
 ;;=^270367
 ;;^UTILITY(U,$J,358.3,7006,0)
 ;;=788.7^^55^575^54
 ;;^UTILITY(U,$J,358.3,7006,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7006,1,4,0)
 ;;=4^788.7
 ;;^UTILITY(U,$J,358.3,7006,1,5,0)
 ;;=5^Urethral Discharge
 ;;^UTILITY(U,$J,358.3,7006,2)
 ;;=^265872
 ;;^UTILITY(U,$J,358.3,7007,0)
 ;;=131.02^^55^575^57
 ;;^UTILITY(U,$J,358.3,7007,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7007,1,4,0)
 ;;=4^131.02
 ;;^UTILITY(U,$J,358.3,7007,1,5,0)
 ;;=5^Urethritis, Trichomonal
 ;;^UTILITY(U,$J,358.3,7007,2)
 ;;=^266955
 ;;^UTILITY(U,$J,358.3,7008,0)
 ;;=597.80^^55^575^55
 ;;^UTILITY(U,$J,358.3,7008,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7008,1,4,0)
 ;;=4^597.80
 ;;^UTILITY(U,$J,358.3,7008,1,5,0)
 ;;=5^Urethritis NOS
 ;;^UTILITY(U,$J,358.3,7008,2)
 ;;=Urethritis, NOS^124214
 ;;^UTILITY(U,$J,358.3,7009,0)
 ;;=788.41^^55^575^58
 ;;^UTILITY(U,$J,358.3,7009,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7009,1,4,0)
 ;;=4^788.41
 ;;^UTILITY(U,$J,358.3,7009,1,5,0)
 ;;=5^Urinary Frequency
 ;;^UTILITY(U,$J,358.3,7009,2)
 ;;=^124396
 ;;^UTILITY(U,$J,358.3,7010,0)
 ;;=788.31^^55^575^62
 ;;^UTILITY(U,$J,358.3,7010,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7010,1,4,0)
 ;;=4^788.31
 ;;^UTILITY(U,$J,358.3,7010,1,5,0)
 ;;=5^Urinary Incontinence,Urge
 ;;^UTILITY(U,$J,358.3,7010,2)
 ;;=^260046
 ;;^UTILITY(U,$J,358.3,7011,0)
 ;;=788.20^^55^575^63
 ;;^UTILITY(U,$J,358.3,7011,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7011,1,4,0)
 ;;=4^788.20
 ;;^UTILITY(U,$J,358.3,7011,1,5,0)
 ;;=5^Urinary Retention
 ;;^UTILITY(U,$J,358.3,7011,2)
 ;;=^295812
